Timothy Wiegand, MD
Director of Medical Toxicology and Toxicology Consult Service,
Associate Clinical Professor of Emergency Medicine
URMC and Strong Memorial Hospital
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is Program Director for the URMC Addiction Medicine Fellowship Program, and the Medical Director for Huther Doyle, an addiction services provider in Rochester, New York, where he works in a collaborative model providing a variety of services for patients with substance use disorders, and serves as facilitator for their Project ECHO program on Pain, Opioid Prescribing and Addiction. In addition to ED, hospital and clinic work treating drug exposures, intoxication, withdrawal and assisting with pain management for patients maintained on medications for opioid use disorder (MOUD) in the ED, hospital and perioperative setting, Dr. Wiegand is involved with medical education and research in toxicology and addiction.
Michael Delman, MD
Medical Director, Seafield Center and Services
Assistant Professor of Medicine, Zucker Hofstra School of Medicine
Kelly S. Ramsey, MD, MPH, MA, FACP
Education Committee Chairperson
Regional Director to ASAM
Chief of Medical Services, NYS OASAS
Dr. Kelly S. Ramsey is an internal medicine physician who has treated substance use disorder since 2004. She is board certified in internal medicine and addiction medicine. Dr. Ramsey currently works as the Chief of Medical Services at NYS OASAS. Dr. Ramsey was the recipient of the NYS DOH Commissioner’s Special Recognition Award for contributions to drug user health in NYS in December 2018. Some of Dr. Ramsey’s clinical interests in addiction include: opioid use disorder, harm reduction, overdose prevention, the impact of language and stigma on healthcare engagement for people who use drugs (PWUD), substance use disorder in pregnant and parenting persons, and HIV and HCV diagnosis, engagement in care, and treatment for PWUD.
Dorothy Lennon, MD, DFASAM
Syracuse Recovery Services
Dr. Dorothy Lennon’s clinical interests include: physician health, stigma reduction, MOUD and 12-step recovery.
Ross Sullivan, MD
Director-Medical Toxicology Consultation Service
Upstate Medical University Hospital-Syracuse
Kristine Torres-Lockhart, MD
Assistant Professor of Medicine and Psychiatry and Behavioral Sciences at Montefiore Medical Center and Albert Einstein College of Medicine
Dr. Torres-Lockhart is board certified in addiction medicine and internal medicine and credentialed as an HIV specialist by the AAHIVM. She is founding director of the Addiction Consult Service at Montefiore’s Weiler Hospital and co-director of the Addiction Medicine rotation for medical trainees. She is focused on integrating addiction medicine into medical education and leads the development and implementation of health system interventions to improve substance use disorder (SUD) care in acute care settings and transitions of care to post-acute and ambulatory care settings.
Merrill Herman, MD
Membership Committee Chair
Associate Professor of Clinical Psychiatry at Montefiore/Einstein
917-564-8771 or 718-920-6770
Dr. Herman has a long-standing interest in the treatment of Co-occurring Psychiatric Disorders and Substance Use Disorders (Dual Diagnosis) including both psychotherapeutic and pharmacologic management. In addition, I have a long-standing interest in the treatment of OUD, especially working with methadone patients. In addition, oversees the Addiction Psychiatry Fellowship at Montefiore/Einstein and is passionate about education in the field. Additionally he is the former Founding President of NYSAM, current member of the Nominating Committee and member of the ASAM National Membership Council.
Aaron D. Fox, MD
Public Policy Chair
Associate Professor of Medicine
Albert Einstein College of Medicine/Montefiore Medical Center
Dr. Aaron Fox is board certified in internal medicine and addiction medicine. His clinical care and research involves opioid use disorder treatment in primary care, syringe services programs, and criminal justice settings. Dr. Fox is the Director of the Bronx Transitions Clinic, which provides a medical home to people who were recently released from jail or prison, and he maintains an NIH-funded program of clinical research focused on buprenorphine treatment interventions.
Norm Wetterau, MD
Public Policy Committee Co-Chair
Physician, Tricounty Family Medicine
Norman Wetterau has been involved in addiction medicine since 1985 and helped start NYSAM as an active chapter. He is a family physician and provides addiction services in his primary care practice and through CASA Trinity in rural NY. He is clinical associate professor of family medicine, University of Rochester and heads up ASAM’s primary care interest group among other things.
Greg Bunt, MD
Alternate Regional Director
Clinical Assistant Professor
NYU Langone Health
Jeffrey Selzer MD, DFASAM
Associate Professor of Psychiatry Hofstra Northwell School of Medicine and Albert Einstein College of Medicine
Dr. Selzer is Medical Director of the Committee for Physician Health (NY’s physician health program), Director of Northwell Health’s Physician Resource Network (Northwell’s EAP for medical students and physicians), and Public Policy Committee Chair for ASAM. His interests in addiction medicine are substance use and substance use disorders in physicians, substance use and substance use disorder treatment public policy, and developing addiction medicine advocacy opportunities for students and physicians. His goall is for ASAM to help our patients receive better care and to help those of us who work in addiction medicine to have better professional lives.
Linda Wang, MD
Co-chair for the Education and Program Committee
Assistant Professor in the Division of General Internal Medicine at the Icahn School of Medicine at Mount Sinai
Dr. Linda Wang is a general internist and addiction medicine specialist who cares for people who use drugs at the REACH Program at Mount Sinai, where she also directs the buprenorphine treatment program. She is the Medical Director for the Hepatitis C and Drug User Health Center of Excellence at the Institute for Advanced Medicine at Mount Sinai, part of the New York State Clinical Education Initiative. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, stigma-free care for people who use drugs, and training current and future clinicians in drug user health.